|
|
||||||||
ORIGINAL RESEARCH |





From the *Hildesheim General Hospital Department of Obstetrics and Gynecology, Hildesheim;
Schaper & Brümmer GmbH & Co. KG, Salzgitter; and
Institut für Angewandte Statistik GmbH, Bielefeld, Germany.
Address reprint requests to: Address correspondence to: Rüdiger Osmers, MD, PhD, Hildesheim General Hospital Department of Obstetrics and Gynecology, Weinberg 1 31134, Hildesheim, Germany; e mail: frauenklinik{at}stk-hildesheim.de.
OBJECTIVE: Several clinical studies suggest that black cohosh may be effective in climacteric complaints. However, evidence of its efficacy based on current quality standards has been limited.
METHODS: This randomized, multicenter, double-blind clinical trial compared the efficacy and tolerability of the isopropanolic black cohosh extract in the treatment of climacteric complaints compared with placebo. A total of 304 patients were randomly allocated to receive tablets corresponding to 40 mg drug or matching placebo daily for 12 weeks. The primary efficacy measure was the change from baseline on the Menopause Rating Scale I; secondary measures included changes in its subscores and safety variables.
RESULTS: Patient groups did not differ in baseline characteristics. The isopropanolic black cohosh extract was more effective than placebo (P < .001) depending on time from symptom onset (P = .014) and follicle-stimulating hormone level (P = .011). The effect size was 0.03 to 0.05 Menopause Rating Scale units which is similar to recent hormone replacement therapy study results (0.036 Menopause Rating Scale units) and may therefore be considered clinically relevant. Women in the early climacteric phase benefited more than in the late phase. The hot flush subscore was the most effective measure of the isopropanolic black cohosh extract's efficacy. There were no relevant group differences in adverse events, laboratory findings, or tolerability.
CONCLUSION: This isopropanolic extract of black cohosh root stock is effective in relieving climacteric symptoms, especially in early climacteric women.
LEVEL OF EVIDENCE: I
This article has been cited by other articles:
![]() |
A. Nedrow, J. Miller, L. H. Huffman, P. Nygren, M. Walker, and H. D. Nelson Alternatives for Menopause--Reply Arch Intern Med, March 12, 2007; 167(5): 515 - 516. [Full Text] [PDF] |
||||
![]() |
K. M. Newton, S. D. Reed, A. Z. LaCroix, L. C. Grothaus, K. Ehrlich, and J. Guiltinan Treatment of Vasomotor Symptoms of Menopause with Black Cohosh, Multibotanicals, Soy, Hormone Therapy, or Placebo: A Randomized Trial Ann Intern Med, December 19, 2006; 145(12): 869 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Cheung Black cohosh and St John's wort reduced climacteric and depressive symptoms Evid. Based Med., October 1, 2006; 11(5): 148 - 148. [Full Text] [PDF] |
||||
![]() |
A. Nedrow, J. Miller, M. Walker, P. Nygren, L. H. Huffman, and H. D. Nelson Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med, July 24, 2006; 166(14): 1453 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Pockaj, J. G. Gallagher, C. L. Loprinzi, P. J. Stella, D. L. Barton, J. A. Sloan, B. I. Lavasseur, R. M. Rao, T. R. Fitch, K. M. Rowland, et al. Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Black Cohosh in the Management of Hot Flashes: NCCTG Trial N01CC1 J. Clin. Oncol., June 20, 2006; 24(18): 2836 - 2841. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Uebelhack, J.-U. Blohmer, H.-J. Graubaum, R. Busch, J. Gruenwald, and K.-D. Wernecke Black Cohosh and St. John's Wort for Climacteric Complaints: A Randomized Trial Obstet. Gynecol., February 1, 2006; 107(2): 247 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reed, K. Newton, A. LaCroix, and L. Grothaus Efficacy and Safety of Isopropanolic Black Cohosh Extract for Climacteric Symptoms Obstet. Gynecol., November 1, 2005; 106(5): 1111 - 1111. [Full Text] [PDF] |
||||
![]() |
Black Cohosh Is Effective in Relieving Menopausal Symptoms Journal Watch (General), May 24, 2005; 2005(524): 3 - 3. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |